U.S. flag

An official website of the United States government

NM_000094.4(COL7A1):c.7344G>A (p.Val2448=) AND Epidermolysis bullosa dystrophica inversa, autosomal recessive

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 16, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001275769.2

Allele description [Variation Report for NM_000094.4(COL7A1):c.7344G>A (p.Val2448=)]

NM_000094.4(COL7A1):c.7344G>A (p.Val2448=)

Gene:
COL7A1:collagen type VII alpha 1 chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p21.31
Genomic location:
Preferred name:
NM_000094.4(COL7A1):c.7344G>A (p.Val2448=)
HGVS:
  • NC_000003.12:g.48570639C>T
  • NG_007065.1:g.29614G>A
  • NM_000094.4:c.7344G>AMANE SELECT
  • NP_000085.1:p.Val2448=
  • NP_000085.1:p.Val2448=
  • LRG_286t1:c.7344G>A
  • LRG_286:g.29614G>A
  • LRG_286p1:p.Val2448=
  • NC_000003.11:g.48608072C>T
  • NM_000094.3:c.7344G>A
Note:
Although this allele was reported to be intronic in the paper by Gardella et al., 1996 (PubMed 8755915), the sequence in Figure 4 was used to confirm that this is now annotated to be at the 3' end of the exon.
Nucleotide change:
IVS95DS, G-A, -1
Links:
OMIM: 120120.0010; dbSNP: rs201728948
NCBI 1000 Genomes Browser:
rs201728948
Molecular consequence:
  • NM_000094.4:c.7344G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Epidermolysis bullosa dystrophica inversa, autosomal recessive
Identifiers:
MedGen: C2673612

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001461241Natera, Inc.
no assertion criteria provided
Pathogenic
(Sep 16, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV001461241.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024